292 related articles for article (PubMed ID: 9703463)
1. Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5'-N-ethyluronamide as A1 and A3 adenosine receptor agonists.
Baraldi PG; Cacciari B; Pineda de Las Infantas MJ; Romagnoli R; Spalluto G; Volpini R; Costanzi S; Vittori S; Cristalli G; Melman N; Park KS; Ji XD; Jacobson KA
J Med Chem; 1998 Aug; 41(17):3174-85. PubMed ID: 9703463
[TBL] [Abstract][Full Text] [Related]
2. Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: insight into the receptor activation switch.
Dal Ben D; Buccioni M; Lambertucci C; Kachler S; Falgner N; Marucci G; Thomas A; Cristalli G; Volpini R; Klotz KN
Biochem Pharmacol; 2014 Jan; 87(2):321-31. PubMed ID: 24161786
[TBL] [Abstract][Full Text] [Related]
3. N6-ethyl-2-alkynyl NECAs, selective human A3 adenosine receptor agonists.
Zhu R; Frazier CR; Linden J; Macdonald TL
Bioorg Med Chem Lett; 2006 May; 16(9):2416-8. PubMed ID: 16487705
[TBL] [Abstract][Full Text] [Related]
4. A2B adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyl adenosine and NECA derivatives.
Vittori S; Costanzi S; Lambertucci C; Portino FR; Taffi S; Volpini R; Klotz KN; Cristalli G
Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):471-81. PubMed ID: 15043167
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and adenosine receptor affinity and potency of 8-alkynyl derivatives of adenosine.
Lambertucci C; Costanzi S; Vittori S; Volpini R; Cristalli G
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1153-7. PubMed ID: 11562976
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.
Gallo-Rodriguez C; Ji XD; Melman N; Siegman BD; Sanders LH; Orlina J; Fischer B; Pu Q; Olah ME; van Galen PJ
J Med Chem; 1994 Mar; 37(5):636-46. PubMed ID: 8126704
[TBL] [Abstract][Full Text] [Related]
7. 2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors.
Klotz KN; Camaioni E; Volpini R; Kachler S; Vittori S; Cristalli G
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):103-8. PubMed ID: 10494877
[TBL] [Abstract][Full Text] [Related]
8. 2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.
Cristalli G; Volpini R; Vittori S; Camaioni E; Monopoli A; Conti A; Dionisotti S; Zocchi C; Ongini E
J Med Chem; 1994 May; 37(11):1720-6. PubMed ID: 8201607
[TBL] [Abstract][Full Text] [Related]
9. 2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists.
Cristalli G; Camaioni E; Vittori S; Volpini R; Borea PA; Conti A; Dionisotti S; Ongini E; Monopoli A
J Med Chem; 1995 Apr; 38(9):1462-72. PubMed ID: 7739005
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of adenosine A2A and A3 receptors in the mouse dendritic cell line XS-106.
Dickenson JM; Reeder S; Rees B; Alexander S; Kendall D
Eur J Pharmacol; 2003 Aug; 474(1):43-51. PubMed ID: 12909194
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.
Jacobson KA; Siddiqi SM; Olah ME; Ji XD; Melman N; Bellamkonda K; Meshulam Y; Stiles GL; Kim HO
J Med Chem; 1995 May; 38(10):1720-35. PubMed ID: 7752196
[TBL] [Abstract][Full Text] [Related]
12. Novel N6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A3 adenosine receptors.
Baraldi PG; Cacciari B; Spalluto G; Ji XD; Olah ME; Stiles G; Dionisotti S; Zocchi C; Ongini E; Jacobson KA
J Med Chem; 1996 Feb; 39(3):802-6. PubMed ID: 8576924
[TBL] [Abstract][Full Text] [Related]
13. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.
Link AA; Kino T; Worth JA; McGuire JL; Crane ML; Chrousos GP; Wilder RL; Elenkov IJ
J Immunol; 2000 Jan; 164(1):436-42. PubMed ID: 10605040
[TBL] [Abstract][Full Text] [Related]
14. Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors.
van Rhee AM; Jiang JL; Melman N; Olah ME; Stiles GL; Jacobson KA
J Med Chem; 1996 Jul; 39(15):2980-9. PubMed ID: 8709132
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
Li AH; Moro S; Forsyth N; Melman N; Ji XD; Jacobson KA
J Med Chem; 1999 Feb; 42(4):706-21. PubMed ID: 10052977
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
Bruns RF; Lu GH; Pugsley TA
Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074
[TBL] [Abstract][Full Text] [Related]
17. 2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
Franchetti P; Cappellacci L; Marchetti S; Trincavelli L; Martini C; Mazzoni MR; Lucacchini A; Grifantini M
J Med Chem; 1998 May; 41(10):1708-15. PubMed ID: 9572897
[TBL] [Abstract][Full Text] [Related]
18. Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.
Siddiqi SM; Jacobson KA; Esker JL; Olah ME; Ji XD; Melman N; Tiwari KN; Secrist JA; Schneller SW; Cristalli G
J Med Chem; 1995 Mar; 38(7):1174-88. PubMed ID: 7707320
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes.
Feoktistov I; Biaggioni I
Biochem Pharmacol; 1998 Mar; 55(5):627-33. PubMed ID: 9515573
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
